Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We have a range sample types for clinical feasibility studies using prospective and retrospect study models to identify intended use or widen assay utility.
Improve performance with validations designed to detect assay limitations, find solutions, improve sensitivity and specificity on chosen disease states.
Our team can undertake the validations of all haemostasis testing including research only assays.
Identifying interferences and adjusting protocols to improve specific and sensitivity
Innovative solutions are transforming diagnostics in the medical field, ensuring accuracy and compliance like never before. Embrace the future of healthcare with our transitional validations designed to enhance laboratory efficiency and patient outcomes.
Method validation / verification is undertaken against a defined protocol / study plan, pre-approved & tailored to be stage appropriate for the development by the customer.
Our team undertake the entire validation process and publish in reputable journals to showcase your device/assay's performance and specifications as required.
We undertake a systematic approach to investigations that begins with pre-defined objectives based on extensive clinical input, sound science and quality risk management. Investigations provided:
Use one of our collaborating laboratories for method specific comparison using same batch of materials
(i.e. samples are analysed by the receiving laboratory in accordance with the test method, and the results are compared with the results obtained by the originating site for the same batches.
The results obtained from both sites are demonstrated to be comparable, against pre-defined acceptance criteria).
Improve performance with validations designed detect assay limitations, find solutions, improve sensitivity and specificity on chosen disease states.
Multisite evaluations using a range of platforms to examine variability and procedural non conformities.
Our Service evaluation are clinically lead.
We perform retrospective and or prospective studies and have access to a wide range of samples and pathologies.
From early-stage R&D to post-market surveillance, we deliver end-to-end testing solutions and performance evaluations across analytical biomedical testing platforms.
7.0 Product realisation
7.3 Design and development
7.3.2 Design and development planning
Method Comparison and Bias Estimation Using Patient Samples
7.3.3 Requirements for Quality and Compliance and manufacturing process”
Bringing inhouse products to clinical use using relevant essential requirements of the IVD Directive 98/79 EC or Regulation 2017/746
Clinical verification
Evaluate the test method over the clinically meaningful range, i.e., where medical decisions are made. Analyze at least 40 samples as CLSI EP9-A2 recommendations
Evaluate the test method using 100 clinically meaningful samples against reference methods and perform data analysis and clinical correlation
Evaluate method stability under varied conditions. Includes solution stability and system suitability parameters.
Minimum of 120 data points used in this study.
Design verification documentation to confirm that the design output meets the design input requirements.
Identifying sample requirements as per verification plan and sourcing them for the study.
Prices are dependent of study size and complexity of requirements
ISOChecks.co.uk